• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Kobe 0065

Kobe 0065

Product ID K5604
Cas No. 436133-68-5
Purity ≥99%
Product Unit SizeCostQuantityStock
5 mg $92.90 In stock
25 mg $365.50 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Kobe 0065 is an inhibitor of Ras that exhibits anticancer chemotherapeutic activities. In vitro, this compound inhibits cell growth and induces apoptosis and in vivo, it decreases tumor growth.

Product Info

Cas No.

436133-68-5

Purity

≥99%

Formula

C15H11ClF3N5O4S

Formula Wt.

449.79

IUPAC Name

N-(3-Chloro-4-methylphenyl)-2-[2,6-dinitro-4-(trifluoromethyl)phenyl]hydrazinecarbothioamide

Solubility

ethanol 10mM with gentle warming water 5 mM with gentle warming

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

K5604 MSDS PDF

Info Sheet

K5604 Info Sheet PDF

References

Shima F, Yoshikawa Y, Ye M, et al. In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction. Proc Natl Acad Sci U S A. 2013 May 14;110(20):8182-7. PMID: 23630290.

Shima F, Yoshikawa Y, Matsumoto S, et al. Discovery of small-molecule Ras inhibitors that display antitumor activity by interfering with Ras·GTP-effector interaction. Enzymes. 2013;34 Pt. B:1-23. PMID: 25034098.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • W0272

    S-(−)-Warfarin >99

    Coumarin, more potent isomer; VKORC1 inhibitor.
    ≥98%
  • A1318

    Adenine

    Endogenous purine nucleotide base, required for sy...
    ≥98%
  • C1613

    Cediranib

    VEGFR inhibitor.
    ≥98%
  • T2970

    Thrombin Receptor Agonist Peptide

    Peptide; PAR1 agonist.
    ≥95%
  • A1016

    S-Acetyl-L-glutathione

    Alters intracellular glutathione levels.
    ≥98%
  • A5035

    5-Aminosalicylic Acid

    Salicylic acid derivative; PPARγ agonist, potenti...
    ≥98%
  • D3329

    7,8-Dihydroxyflavone Hydrate

    TrkB agonist.
    ≥99%
  • A1371

    Adrenorphin

    Endogenous opioid peptide; μOR and κOR agonist.
    ≥95%
  • S6235

    Spironolactone

    Mineralocorticoid, aldosterone, AR antagonist, ENa...
    ≥97%
  • Z4833

    ZM-336372

    c-Raf activator, tyrosine kinase inhibitor.
    ≥98%
  • E537334

    Enniatin B

    Mycotoxin contaminant found in cereal grains.
    ≥99%
  • G0146

    Galanin, human

    Endogenous neuropeptide, involved in nociception, ...
    ≥98%
  • H1643

    Helodermin

    Peptide originally found in Heloderma.
    ≥95%
  • V5725

    Voglibose

    α-glucosidase inhibitor, potential GLP-1 agonist,...
    ≥98%
  • C2916

    Chenodeoxycholic Acid

    Endogenous bile acid; FXR agonist.
    ≥98%
  • N5072

    NMS-1286937

    PLK1 inhibitor.
    ≥98%
  • C0262

    L-Carnitine

    Endogenous quaternary ammonium, required for fatty...
    ≥98%
  • D3355

    Diosgenin

    Steroidal saponin found in Dioscorea.
    ≥98%
  • C2847

    Chlormadinone Acetate

    Synthetic steroid hormone; AR and ER antagonist.
    ≥96%
  • L1628

    Ac-LEHD-pNa

    Caspase 9 substrate.
    ≥95%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only